Literature DB >> 10223419

Consensus statement on the diagnosis of multiple system atrophy.

S Gilman1, P A Low, N Quinn, A Albanese, Y Ben-Shlomo, C J Fowler, H Kaufmann, T Klockgether, A E Lang, P L Lantos, I Litvan, C J Mathias, E Oliver, D Robertson, I Schatz, G K Wenning.   

Abstract

We report the results of a consensus conference on the diagnosis of multiple system atrophy (MSA). We describe the clinical features of the disease, which include four domains: autonomic failure/urinary dysfunction, parkinsonism and cerebellar ataxia, and corticospinal dysfunction. We set criteria to define the relative importance of these features. The diagnosis of possible MSA requires one criterion plus two features from separate other domains. The diagnosis of probable MSA requires the criterion for autonomic failure/urinary dysfunction plus poorly levodopa responsive parkinsonism or cerebellar ataxia. The diagnosis of definite MSA requires pathological confirmation.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1999        PMID: 10223419     DOI: 10.1016/s0022-510x(98)00304-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  251 in total

Review 1.  Multiple system atrophy: pathophysiology and management.

Authors:  G K Wenning; S Braune
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Diagnosis and management of atypical parkinsonian syndromes.

Authors:  David J Brooks
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

3.  Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's disease.

Authors:  D E Riley; T C Chelimsky
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

4.  Subclinical nigrostriatal dopaminergic denervation in the cerebellar subtype of multiple system atrophy (MSA-C).

Authors:  Esteban Muñoz; Alex Iranzo; Sebastian Rauek; Francisco Lomeña; Judith Gallego; Doménec Ros; Joan Santamaría; Eduardo Tolosa
Journal:  J Neurol       Date:  2011-06-03       Impact factor: 4.849

5.  Orthostatic Hypotension in Multiple System Atrophy.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-05       Impact factor: 3.598

6.  Dorfin localizes to the ubiquitylated inclusions in Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and amyotrophic lateral sclerosis.

Authors:  Nozomi Hishikawa; Jun-Ichi Niwa; Manabu Doyu; Takashi Ito; Shinsuke Ishigaki; Yoshio Hashizume; Gen Sobue
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

7.  Quantitative evaluation of brainstem involvement in multiple system atrophy by diffusion-weighted MR imaging.

Authors:  Masato Kanazawa; Takayoshi Shimohata; Kenshi Terajima; Osamu Onodera; Keiko Tanaka; Shoji Tsuji; Kouichirou Okamoto; Masatoyo Nishizawa
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

8.  Different loss of dopamine transporter according to subtype of multiple system atrophy.

Authors:  Hae Won Kim; Jae Seung Kim; Minyoung Oh; Jungsu S Oh; Sang Joo Lee; Seung Jun Oh; Sun Ju Chung; Chong Sik Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-19       Impact factor: 9.236

9.  Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy.

Authors:  Nadia Stefanova; Markus Reindl; Manuela Neumann; Christian Haass; Werner Poewe; Philipp J Kahle; Gregor K Wenning
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

Review 10.  Brainstem in multiple system atrophy: clinicopathological correlations.

Authors:  Eduardo E Benarroch
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.